| 1 | Acetate | 1件: Acetate Acetate | - | - | - | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
| 2 | ADVATE | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 3 | ADVATE (rAHF - PFM) | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 4 | ADVATE (rAHF-PFM) | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 5 | ADVATE 1000 IU powder and solvent for solution for injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 6 | ADVATE 1000IU powder and solvent for solution for injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 7 | ADVATE 500 IU powder and solvent for solution for injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 8 | Alphanate | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 9 | Alphanate 1000 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 10 | Alphanate 1500 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 11 | Alphanate SD/HT | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 12 | ALPHANATE*INF 1F 1000UI+F 10ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 13 | ALPHANATE*INF 1F 1500UI+F 10ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 14 | ALPHANATE*INF 1F 250UI+F 5ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 15 | ALPHANATE*INF 1F 500UI+F 5ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 16 | Antihemophilic Factor (Recombinant) | - | - | - | - | 1件: 288 288 |
| 17 | APCC, aPCC + TXA | - | - | - | - | 1件: 288 288 |
| 18 | ARC 1779 | - | - | - | - | 2件: 64 64, 288 |
| 19 | ARC1779 | - | - | - | - | 2件: 64 64, 288 |
| 20 | ARC1779 Injection | - | - | - | - | 2件: 64 64, 288 |
| 21 | BAX 111 | - | - | - | - | 1件: 288 288 |
| 22 | BAX111 | - | - | - | - | 1件: 288 288 |
| 23 | Biostate | - | - | - | - | 1件: 288 288 |
| 24 | Biostate® | - | - | - | - | 1件: 288 288 |
| 25 | BIVV001 (rFVIIIFc-VWF-XTEN) | - | - | - | - | 1件: 288 288 |
| 26 | Blood coagulation Factor VIII and vWF, human | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 27 | Blood sample | - | - | - | - | 18件: 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
| 28 | BORTEZOMIB | 1件: Bortezomib Bortezomib | 1件: D03150
D03150
| 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331 |
| 29 | Catridecacog | 1件: Catridecacog Catridecacog | 1件: D10532
D10532
| - | - | 2件: 97 97, 288 |
| 30 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 29件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
| 31 | Cluvot | - | - | - | - | 1件: 288 288 |
| 32 | Coagadex | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 33 | Coagulación factor VIII | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 34 | Coagulation factor VIII | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 35 | Coagulation factor X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 36 | Coagulation factor XIII | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
| 37 | CoFactor | - | - | - | - | 3件: 6 6, 265, 288 |
| 38 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 45件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
| 39 | DDAVP | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 75 75, 288 |
| 40 | DDAVP (Desmopressin) | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 288 288 |
| 41 | Desmopressin | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 5件: 6 6, 64, 72, 225, 288 |
| 42 | Desmopressin acetate | 2件: Acetate Acetate, Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 64 64, 288 |
| 43 | Desmopressine | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 225 225, 288 |
| 44 | Diagnostic Test: blood sample , doppler of uterine vessel and placenta | - | - | - | - | 1件: 288 288 |
| 45 | Diagnostic Test: fibrinogen plasma concentration, coagulation factor XIII activity | 2件: Factor XIII (human) Factor XIII (human), Fibrinogen human | - | - | - | 1件: 288 288 |
| 46 | Efanesoctocog alfa | 1件: Efanesoctocog alfa Efanesoctocog alfa | - | - | - | 1件: 288 288 |
| 47 | Efanesoctocog alfa (BIVV001) | 1件: Efanesoctocog alfa Efanesoctocog alfa | - | - | - | 1件: 288 288 |
| 48 | Emicizumab | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 49 | Emicizumab (ACE910, RO5534262) | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 50 | Emicizumab Injection | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 51 | Eqwilate | - | - | - | - | 1件: 288 288 |
| 52 | F13CD | - | - | - | - | 1件: 288 288 |
| 53 | F8VR | - | - | - | - | 1件: 288 288 |
| 54 | FACTANE 200 IU/ml | - | - | - | - | 1件: 288 288 |
| 55 | Factor VIII | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 56 | Factor VIII concentrate | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 57 | Factor von Willebrand | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 58 | FACTOR X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 59 | Factor XIII | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 3件: 51 51, 97, 288 |
| 60 | Factor XIII Concentrate (Human) | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
| 61 | Factor XIII Concentrate (Human), Pasteurized | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
| 62 | Fanhdi | - | - | - | - | 1件: 288 288 |
| 63 | FANHDI 100 UI | - | - | - | - | 1件: 288 288 |
| 64 | Fanhdi 100 UI FVIII-120 UI FVW | - | - | - | - | 1件: 288 288 |
| 65 | FANHDI 25 UI | - | - | - | - | 1件: 288 288 |
| 66 | Fanhdi 25 UI FVIII-30 UI FVW | - | - | - | - | 1件: 288 288 |
| 67 | FANHDI 250UI*1F 250UI+F 10ML | - | - | - | - | 1件: 288 288 |
| 68 | FANHDI 50 UI | - | - | - | - | 1件: 288 288 |
| 69 | Fanhdi 50 UI FVIII-60 UI FVW | - | - | - | - | 1件: 288 288 |
| 70 | FANHDI*INF FL 250UI+SIR SOLV+S | - | - | - | - | 1件: 288 288 |
| 71 | FANHDI*INF FL 500UI+SIR SOLV+S | - | - | - | - | 1件: 288 288 |
| 72 | FANHDI*INF FL1000UI+SIR SOLV+S | - | - | - | - | 1件: 288 288 |
| 73 | FANHDI*INF FL250UI+SIR SOLV+S | - | - | - | - | 1件: 288 288 |
| 74 | Fibrinogen | 1件: Fibrinogen human Fibrinogen human | - | - | - | 3件: 14 14, 65, 288 |
| 75 | Fibrogammin P | - | - | - | - | 1件: 288 288 |
| 76 | Fibrogammin® P | - | - | - | - | 1件: 288 288 |
| 77 | Fibrogammin®P | - | - | - | - | 1件: 288 288 |
| 78 | FXIII Concentrate (Human) | - | - | - | - | 1件: 288 288 |
| 79 | FXIII Concentrate (Human) (FXIII) | - | - | - | - | 1件: 288 288 |
| 80 | Haemate P | - | - | - | - | 1件: 288 288 |
| 81 | Haemate P® (Human Coagulation Factor VIII) | 2件: Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | 1件: 288 288 |
| 82 | Haemate-P, Wilate | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 83 | Haemate® P 250 | - | - | - | - | 1件: 288 288 |
| 84 | Hemlibra | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 85 | Hemlibra® | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 86 | HEMOFIX | - | - | - | - | 1件: 288 288 |
| 87 | HUMAN COAGULATION FACTOR VIII | 2件: Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | 1件: 288 288 |
| 88 | Human coagulation Factor VIII / von Willebrand Factor | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 89 | Human coagulation factor VIII associated with Von Willebrand factor (VWF) | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 90 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX | 3件: Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 91 | Human Coagulation FACTOR X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 92 | Human factor X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
| 93 | HUMAN VON WILLEBRAND FACTOR | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 94 | Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII) | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 95 | Human VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 |
| 96 | Humate-P | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 97 | IL-11 | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 1件: 288 288 |
| 98 | Interleukin 11 | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 1件: 288 288 |
| 99 | Interleukin-11 | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 2件: 96 96, 288 |
| 100 | Marketed plasma-derived VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 |
| 101 | Minirin | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 64 64, 288 |
| 102 | Minrin | - | - | - | - | 1件: 288 288 |
| 103 | Natriumchlorid | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 288 288 |
| 104 | Natriumchlorid 0,9 % | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 288 288 |
| 105 | Neumega (Oprelvekin, Interleukin 11, IL-11) | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 1件: 288 288 |
| 106 | NN 1841 | - | - | - | - | 1件: 288 288 |
| 107 | NN1841 | - | - | - | - | 1件: 288 288 |
| 108 | OBI-1 | - | - | - | - | 1件: 288 288 |
| 109 | OBIZUR | 1件: Susoctocog alfa Susoctocog alfa | 1件: D10831
D10831
| - | - | 1件: 288 288 |
| 110 | Obyoctocog alfa | - | - | - | - | 1件: 288 288 |
| 111 | Octanate | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 112 | OCTANATE 100 UI/ml, poudre et solvant pour solution injectable | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 113 | OCTANATE 50 UI/ml, poudre et solvant pour solution injectable | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 114 | OCTOCOG ALFA | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 115 | Octostim | - | - | - | - | 2件: 64 64, 288 |
| 116 | Oprelvekin | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 1件: 288 288 |
| 117 | Oprelvekin, Interleukin 11, IL-11 | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 1件: 288 288 |
| 118 | Optivate | - | - | - | - | 1件: 288 288 |
| 119 | Optivate® (Human Coagulation Factor VIII) | 1件: Antihemophilic factor human Antihemophilic factor human | - | - | - | 1件: 288 288 |
| 120 | Other: Use of a postpartum diary and additional blood draws | - | - | - | - | 1件: 288 288 |
| 121 | Other: Use of a postpartum diary and additional blood draws. | - | - | - | - | 1件: 288 288 |
| 122 | Physiologische Kochsalzlösung Fresenius - Infusionslösung | - | - | - | - | 1件: 288 288 |
| 123 | Phytomenadione | 1件: Phylloquinone Phylloquinone | 1件: D00148
D00148
| - | - | 1件: 288 288 |
| 124 | Plasma-derived FVIII/VWF concentrate | - | - | - | - | 1件: 288 288 |
| 125 | Prednisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| 126 | Prothrombin | 1件: Prothrombin Prothrombin | - | - | - | 1件: 288 288 |
| 127 | Prothrombin Complex Concentrate | 2件: Factor IX Complex (Human) Factor IX Complex (Human), Prothrombin | - | - | - | 1件: 288 288 |
| 128 | RAHF | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: D02958
D02958
| - | - | 1件: 288 288 |
| 129 | Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 130 | Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 131 | Recombinant factor VIIII (rFVIII) | - | - | - | - | 1件: 288 288 |
| 132 | Recombinant Factor XIII | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
| 133 | Recombinant Factor XIII (rFXIII) | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 2件: 97 97, 288 |
| 134 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO | 2件: Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | 1件: 288 288 |
| 135 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 136 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 137 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN | 2件: Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 138 | Recombinant human von Willebrand Factor | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 139 | Recombinant interleukin-11 | 1件: Oprelvekin Oprelvekin | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 1件: 288 288 |
| 140 | Recombinant porcine coagulation factor VIII (B domain deleted) | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 141 | Recombinant porcine coagulation factor VIII (B-domain deleted) | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 142 | Recombinant Von Willebrand factor | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 143 | Recombinant von Willebrand Factor (rVWF) | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 144 | Recombinant von Willebrand Factor 1300IU | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 145 | Recombinant von Willebrand Factor 650IU | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 146 | Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII) | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 147 | Recomibnant human Von Willebrand Factor | 2件: Von Willebrand factor human Von Willebrand factor human, Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 148 | RFVIIa | 1件: Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | 1件: D00172
D00172
| - | - | 1件: 288 288 |
| 149 | RFVIIa, rFVIIa + TXA | 1件: Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | 1件: D00172
D00172
| - | - | 1件: 288 288 |
| 150 | RFVIII | - | - | - | - | 1件: 288 288 |
| 151 | Rituxan | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 46 46, 60, 256, 288 |
| 152 | Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
| 153 | RO5534262 EMICIZUMAB | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
| 154 | Rurioctocog alfa pegol | 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol | 1件: D10760
D10760
| - | - | 1件: 288 288 |
| 155 | RVWF | - | - | - | - | 1件: 288 288 |
| 156 | Saline solution | - | - | - | - | 4件: 2 2, 34, 288, 299 |
| 157 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
| 158 | Simvastatine | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 6 6, 13, 288 |
| 159 | Sodium chloride | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 21件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299 |
| 160 | SODIUM CHLORIDE SOLUTION 0.9% | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 3件: 60 60, 288, 299 |
| 161 | Standard of Care for Haemophilia A | - | - | - | - | 1件: 288 288 |
| 162 | Standard of Care FVIII Replacement therapy | - | - | - | - | 1件: 288 288 |
| 163 | Steroid | - | - | - | - | 1件: 288 288 |
| 164 | Sublingual videomicroscopy | - | - | - | - | 1件: 288 288 |
| 165 | TAK-672 | - | - | - | - | 1件: 288 288 |
| 166 | Tranexamic acid | 1件: Tranexamic acid Tranexamic acid | 1件: D01136
D01136
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 6件: 46 46, 70, 215, 227, 288, 299 |
| 167 | Tranexamic Acid Injection [Cyklokapron] | 1件: Tranexamic acid Tranexamic acid | 1件: D01136
D01136
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 288 288 |
| 168 | Uterine | - | - | - | - | 3件: 118 118, 280, 288 |
| 169 | Vessel | - | - | - | - | 4件: 13 13, 51, 271, 288 |
| 170 | VEYONDI 650IU powder and solvent for solution for injection | - | - | - | - | 1件: 288 288 |
| 171 | Veyvondi | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 172 | VEYVONDI 1300I IU powder and solvent for solution for injection | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 173 | VEYVONDI 1300IU powder and solvent for solution for injection | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 174 | VEYVONDI 650IU powder and solvent for solution for injection | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 175 | Von willebrand factor | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 2件: 64 64, 288 |
| 176 | Von Willebrand factor (Recombinant) | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 177 | Von Willebrand factor and coagulation factor VIII in combination | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 178 | Von Willebrand Factor Antigen | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 179 | Von Willebrand Factor Ristocetin Cofactor | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 180 | Von Willebrand Faktor | - | - | - | - | 1件: 288 288 |
| 181 | Voncento | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 182 | Voncento, Biostate® | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 183 | Voncento® | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 184 | VONICOG ALFA | 1件: Vonicog alfa Vonicog alfa | 1件: D08681
D08681
| - | - | 1件: 288 288 |
| 185 | VWD factor VIII concentrate | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 |
| 186 | VWF replacement therapy with Wilate | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 187 | VWF SD-35-DH | - | - | - | - | 1件: 288 288 |
| 188 | VWF-containing products | - | - | - | - | 1件: 288 288 |
| 189 | VWF/FVIII products | - | - | - | - | 1件: 288 288 |
| 190 | WILATE | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 191 | Wilate 1000 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 192 | WILATE 1000 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 193 | WILATE 450 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 194 | Wilate 500 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 195 | WILATE 500 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 196 | WILATE 900 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 197 | WILATE® 450 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
| 198 | WILFACTIN | - | - | - | - | 1件: 288 288 |
| 199 | Willfact | - | - | - | - | 1件: 288 288 |
| 200 | Wiloctin | - | - | - | - | 1件: 288 288 |